Update on the diagnosis of the pheochromocytoma.

M Araujo-Castro, E Achote, O F Arroyo Ripoll

Journal: Hipertension y riesgo vascular 2025;42(1):43-51

PMID: 39394015

Abstract

Pheochromocytoma is a rare neuroendocrine tumour that develops from chromaffin cells in the adrenal medulla and is characterised by the excessive production of catecholamines and their metabolites. Diagnostic confirmation is performed by detecting elevated levels of catecholamines and/or their metabolites in plasma or 24-h urine. In the case of moderate elevations of normetanephrine, the clonidine suppression test may be useful to differentiate between endogenous hypersecretion and false positive results. Once the biochemical diagnosis is performed, the tumour localisation is carried out using imaging techniques and sometimes with nuclear medicine imaging tests. Furthermore, in all patients with pheochromocytomas it is recommended to perform a genetic study to identify hereditary disorders that may be present in more than 30% of cases and to perform a cardiological evaluation to rule out the presence of cardiovascular involvement secondary to the catecholamine hypersecretion.

Copyright © 2025 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved.

Address: Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Servicio de Endocrinología Clínica y Metabolismo, Universidad de Antioquia, Medellín, Colombia.; Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. Electronic address: [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.